Trials / Completed
CompletedNCT01765855
An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects
AN OPEN-LABEL, SINGLE-DOSE, MASS-BALANCE STUDY TO ASSESS THE DISPOSITION OF 14C-LABELED PRT054021 IN HEALTHY MALE SUBJECTS
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Portola Pharmaceuticals · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a open label, single center, single oral dose, study of PRT054021, in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betrixaban single oral dose |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2013-01-10
- Last updated
- 2023-08-04
Source: ClinicalTrials.gov record NCT01765855. Inclusion in this directory is not an endorsement.